Injection of Hyaluronic Acid Versus Corticosteroid for Treatment of Trigger Finger
NCT ID: NCT04645303
Last Updated: 2020-11-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
EARLY_PHASE1
100 participants
INTERVENTIONAL
2020-11-06
2021-06-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hyaluronic acid
1mL of hyaluronic acid (20 mg/2 mL; Hyalgan, Fidia, Abano Terme, Italy) infiltration at A1-Pulley under ultrasound guidance after subcutaneous 2% lidocaine without epinephrine infiltration of the skin overlying the A1-pulley.
hyaluronic acid (20 mg/2 mL)
A1-Pulley infiltration for trigger finger
Triamcinolone acetonide
1 mL of Triamcinolone acetonide 10mg/ml infiltration at A1-Pulley under ultrasound guidance after subcutaneous 2% lidocaine without epinephrine infiltration of the skin overlying the A1 pulley.
Triamcinolone acetonide 10mg/ml
A1-Pulley infiltration for trigger finger
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hyaluronic acid (20 mg/2 mL)
A1-Pulley infiltration for trigger finger
Triamcinolone acetonide 10mg/ml
A1-Pulley infiltration for trigger finger
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with a clinical diagnosis of trigger finger grade 1-3 on the Quinnell grading scale and confirmed diagnosis by ultrasound.
Exclusion Criteria
* Prior injection within 6 months
* Prior operation of the affected finger
* Presence of any contracture in the proximal interphalangeal or metacarpophalangeal joint, and
* History of diabetes, hypothyroidism, and
* Rheumatic or connective tissue disease
* Allergy to triamcinolone or hyaluronic acid
* Pregnancy
* Secondary triggering e.g. Trauma, infection
* Trigger finger symptoms duration \>6 months
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dubai Health Authority
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sahar Said Khalil
Specialist Senior Registrar- Physical Medicine and Rehabilitation Department- Dubai Hospital- UAE( co-affiliation: Assistant Professor Rheumatology, physical Medicine and rehabilitation- Zagazig University- Egypt)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sahar S Khalil, SSR
Role: PRINCIPAL_INVESTIGATOR
Specialist Senior Registrar- Physical Medicine and rehabilitation Department- Dubai hospital
Mohamed M Abdulla, Consultant
Role: STUDY_CHAIR
Consultant and Head of Physical Medicine and rehabilitation Department- Dubai hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dubai Hospital- Dubai Health Authority
Dubai, , United Arab Emirates
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Liu DH, Tsai MW, Lin SH, Chou CL, Chiu JW, Chiang CC, Kao CL. Ultrasound-Guided Hyaluronic Acid Injections for Trigger Finger: A Double-Blinded, Randomized Controlled Trial. Arch Phys Med Rehabil. 2015 Dec;96(12):2120-7. doi: 10.1016/j.apmr.2015.08.421. Epub 2015 Sep 1.
Callegari L, Spano E, Bini A, Valli F, Genovese E, Fugazzola C. Ultrasound-guided injection of a corticosteroid and hyaluronic acid: a potential new approach to the treatment of trigger finger. Drugs R D. 2011;11(2):137-45. doi: 10.2165/11591220-000000000-00000.
Abate M, Schiavone C, Salini V. The use of hyaluronic acid after tendon surgery and in tendinopathies. Biomed Res Int. 2014;2014:783632. doi: 10.1155/2014/783632. Epub 2014 May 8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DSREC-12/2019_03
Identifier Type: -
Identifier Source: org_study_id